Series C funding round for Inversago Pharma raising $69M in October 2022
Series C funding round for Inversago Pharma raising $69M in October 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Private | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Venture Capital | — |
| Angel | Ed Mathers |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$111M
Top Valuation
-
Inversago Pharma raised $69M in a Series C round.
The round was announced on 10/01/22.